Bharat Serums and Vaccines Limited

Bharat Serums and Vaccines Limited A Mankind Group Company Bharat Serums and Vaccines Limited (BSV) is a Mankind Group Company.

Our mission at BSV is to preserve, protect, & enhance quality of life while we remain committed to ‘Bringing Life to Life’. Our values of Transparency, Agility, Accountability, and Collaboration, hold us in good stead in every step of our patient journey. Numerous pharmaceutical, biotech, & biological products have been developed since the inception of BSV in 1971. We are driven by the goal of improving health & saving lives, through our innovative treatments & cures for patients across the globe. We do this in the critical therapeutic areas of women’s health, critical care, @ IUI-IVF. One of India’s leading biopharmaceutical companies, we keep the patient at the center of all our endeavors, and work towards widening accessibility of our products to reach patients and deliver positive outcomes.

A Proud Milestone!
21/01/2026

A Proud Milestone!

India’s life sciences innovation moment is here.Manthan 2.0 organized by the VASUs Foundation, curated a comprehensive ...
21/01/2026

India’s life sciences innovation moment is here.

Manthan 2.0 organized by the VASUs Foundation, curated a comprehensive session on the need to heighten innovation and R&D in life sciences in India. Setting the context, in her keynote address, Dr. Renu Swarup (Former Secretary to the Government of India, Department of Biotechnology, Ministry of Science & Technology) emphasized that incremental innovation will no longer suffice and how India must now move towards an ecosystem-led sustained innovation, powered by the 3C’s- Capacity, Collaboration and Cutting-edge technology.

Following the inspiring keynote was an insightful panel discussion on The Future of Lifesciences R&D in India: The Innovation Leap” Sanjiv Navangul, MD & CEO, BSV (A Mankind Group Company), joined eminent industry leaders to shape the conversation on the need to strengthen the pillars of innovation, be it policy, people and skill, and academia partnerships. Drawing from BSV’s own journey, Sanjiv highlighted the innovation story of BSV’s Rh(o) Immunoglobulin- India’s first biologic to go global-backed by a first-of-its-kind 20,000-patient study. He further underscored the need for deep collaboration between industry, government and regulators, citing BSV’s work on region-specific anti-snake venom, where partnerships have led to improved access and strengthened public health outcomes.

Sudarshan Jain (Secretary-General, Indian Pharmaceutical Alliance) reinforced the need for strong research funding and enabling policy frameworks, while KG Ananthakrishnan (Ex Secretary-General, OPPI) highlighted the critical role of industry–academia partnerships and the need for researchers to gain both lab and industry experience.

The message from the panel was clear- exponential innovation demands collective action. With aligned stakeholders and a shared commitment to excellence, India’s life sciences ecosystem is ready to move from a promise to global leadership.

Season's Greetings!
25/12/2025

Season's Greetings!

We are proud of our Ambernath Team for being recognized with a Silver at the India Green Manufacturing Challenge 2025 or...
23/12/2025

We are proud of our Ambernath Team for being recognized with a Silver at the India Green Manufacturing Challenge 2025 organized by International Research Institute for Manufacturing®, India.

This award is a testament to our continuous dedication towards sustained green manufacturing practices. It demonstrates our collective responsibility towards our planet and the future!

It was an insightful learning to hear Sanjiv Navangul, MD & CEO, BSV (A Mankind Group Company) in the panel discussion o...
12/12/2025

It was an insightful learning to hear Sanjiv Navangul, MD & CEO, BSV (A Mankind Group Company) in the panel discussion on 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗖𝗼𝗻𝘃𝗲𝗿𝗴𝗲𝗻𝗰𝗲 𝗼𝗳 𝗚𝗿𝗼𝘄𝘁𝗵, 𝗣𝗿𝗼𝗳𝗶𝘁, 𝗮𝗻𝗱 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆.

The high- profile panel comprised Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (IPA); Naveen Narayanan, Global Head Human Resources, Biocon Biologics; Shweta Rai, Managing Director-India and Country Division Head of South Asia Bayer Pharmaceutical; Sachin Dharap, Chief Financial Officer, Aragen Lifesciences; Dr Garima Dadhich, Associate Professor & Head- Business Environment Indian Institute of Corporate Affairs (IICA); and moderator- Charu Gupta, Executive Director- Sustainability & Climate Change, Deloitte.

The panel highlighted the need for sustainability to be viewed as a business strategy that maximises stakeholder value!

Sanjiv Navangul covered a few critical points in the discussion:

• Biologics allows for optimising supply chain management, reducing costs and gearing towards sustainability.
• There needs to be a shift- from that of cost to value. This will usher a higher level of sustainability within the industry
• Next decade belongs to biologics- in other words, focus is to ensure that innovative treatments will lead to increased health benefits and bring social & economic sustainability to the fore.
• For this to happen, it is imperative to get it first time right- processes, documentation etc., in the development stages of biologics need to transparent. Not only should they address the regulatory landscapes across the globe, they should also keep patient's interests / benefits, in mind.

The Inaugural plenary session of the 7th CII Pharma and Lifesciences Summit 2025 had a power panel comprising Dr. Jite...
12/12/2025

The Inaugural plenary session of the 7th CII Pharma and Lifesciences Summit 2025 had a power panel comprising Dr. Jitendra Singh, Hon’ble Minister of State (Independent Charge) for Science & Technology and Earth Sciences; Dr Chandrashekhar Ranga, Joint Drugs Controller General of India (DCGI), Central Drugs Standard Control Organization (CDSCO); Sanjiv Navangul, MD & CEO, BSV ( A Mankind Group Company) ; Shweta Rai, Managing Director- India and Country Division Head of South Asia, Bayer Pharmaceutical and Dr Rajesh Jain, Chairman, CII National Committee on Biotechnology & Managing Director, Panacea Biotec Ltd.

𝗧𝗵𝗲𝗺𝗲𝗱 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀, 𝗣𝗿𝗼𝗺𝗶𝘀𝗲 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗣𝗹𝗮𝗻𝗲𝘁: 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗹𝗲 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 𝗶𝗻 𝗜𝗻𝗱𝗶𝗮𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 & 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀, the Minister set the context highlighting the transformative growth of the pharma and Lifesciences sector in India. He highlighted that collaboration has been the catalyst of this transformation, pointing to several success stories achieved through multi- stakeholder collaborations.

Following the Minister address, Sanjiv Navangul, MD & CEO, BSV highlighted a few key trends that will unlock progress and sustainable growth of the Lifesciences industry in India:

• 𝗦𝗵𝗶𝗳𝘁 𝘁𝗼 𝗔𝗔𝗔: While access and affordability continue to be integral to the industry, we are now witnessing the emergence of the AAA principle - that of Access, Affordability & Accountability- embracing accountability towards our communities, our planet and our future.

• 𝗥𝗲𝗯𝗿𝗮𝗻𝗱 𝘁𝗵𝗲 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆: No longer should India be just remembered as ‘the pharmacy of the world’ . We are witnessing the shift towards biologics, R& D and innovation- it’s time to rebrand India as a ‘Global Pharma Powerhouse.’

• 𝗘𝗺𝗲𝗿𝗴𝗲𝗻𝗰𝗲 𝗼𝗳 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝟱.𝟬: We have successfully navigated from industry 4.0 (digital and automation focus) to industry 5.0 - to a circular economy.

As rightly summarised, it’s about unlocking a '𝗕𝗶𝗼𝗽𝗼𝘀𝗶𝘁𝗶𝘃𝗲 𝗙𝘂𝘁𝘂𝗿𝗲': a future where sustainability is the norm. There is a need to integrate technology, human interactions and sustainability to build a healthy future, ensuring that tomorrow’s medicines are developed with planetary health and patient outcomes at the core.

“Let’s empower women to own their own health journeys. This calls for focus on building awareness, widening access, brin...
05/12/2025

“Let’s empower women to own their own health journeys. This calls for focus on building awareness, widening access, bringing affordability, and ushering acceptance of women as an integral component of the healthcare ecosystem”, said Sivani Sarma Deka, COO – India Business, BSV (A Mankind Group Company) at a powerful panel on “Women’s Health: Dignity, Dialogue & Data” at the IHW Patient First Summit 2025.

Sharing her insights alongside industry veteran Dr. Ameet Patki, Medical Director & President ISAR and Dr. Saloni Singh (Director- Insurance Partnership, LivLong36), she highlighted the need for a patient-first approach!

She spoke of motherhood & parenthood, and the advanced scientific treatments made available by leading biopharma major BSV, that brings science to patients. She spotlit the need for partnerships and collaborations that can go a long way in building an inclusive framework for patient care . She also highlighted the need for real world data that can re-define treatment protocols, quoting the pan- India, multi - centre RhTYM study conducted by BSV, as a case in point. She emphasised that women need to actively participate and make informed health choices, and that the future of women’s health is all about holistic, lifelong wellness!

A wonderful opportunity to hear Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines Limited (A Mankind Group Company) ...
14/11/2025

A wonderful opportunity to hear Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines Limited (A Mankind Group Company) share his insights on Leadership.

A Celebration of Sports, Equality, and Diversity!For us at BSV (A Mankind Group Company), the ICC Women’s Cricket Cup wa...
06/11/2025

A Celebration of Sports, Equality, and Diversity!

For us at BSV (A Mankind Group Company), the ICC Women’s Cricket Cup was more than a historic win! As one of the few women’s health–focused companies in India, we believe that women’s health, fitness, and safety are equally critical.

And we truly celebrated this win together! Sanjiv Navangul, MD & CEO—and a passionate cricket lover—articulated valuable corporate lessons inspired by the victory. Our leaders, Rahul Adakmol and Sivani Sarma Deka, highlighted the need for a conducive ecosystem for women to flourish, and how vulnerability and humility can be strengths for progress.

The quiz trivia, the enthusiasm, and the sports spirit couldn’t get any better!

The BSV Cricket League—with both men and women donning jerseys—is now the much-awaited sporting event of the year…

More updates coming soon!

See you today at CPHI Frankfurt! We look forward to meeting all our customers, partners and friends at Messe Frankfurt, ...
28/10/2025

See you today at CPHI Frankfurt! We look forward to meeting all our customers, partners and friends at Messe Frankfurt, Germany!

We take this opportunity to showcase our manufacturing and R&D capabilities and are eager to share updates on how our products can serve your business.

Please visit us
🗓️- 28th to 30th October
📍- Hall 3.1, Stand No. G6

To book meetings reach us at connect4cphi@mankindpharma.com

World Urticaria Day 2025 Discover ways to with Dr. Anil Ganjoo
01/10/2025

World Urticaria Day 2025

Discover ways to with Dr. Anil Ganjoo

Living with Chronic Urticaria is a 24 hour struggle.This World Urticaria Day, "DITCH THE ITCH" and take a step towards m...
01/10/2025

Living with Chronic Urticaria is a 24 hour struggle.

This World Urticaria Day, "DITCH THE ITCH" and take a step towards managing allergies.

Address

Navi Mumbai

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Telephone

+91-22-4504 3456

Website

https://www.linkedin.com/company/bharat-serums-&-vaccines-limited/

Alerts

Be the first to know and let us send you an email when Bharat Serums and Vaccines Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Bharat Serums and Vaccines Limited:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

Bharat Serums And Vaccines Limited is one of the fastest growing bio pharmaceutical companies in India.

For over 4 decades now, we at Bharat Serums and Vaccines Ltd. (BSVL) have used our scientific resources to develop a range of biological, biotech and pharmaceutical products. Today, as we influence patient outcomes in the therapeutic areas of Women’s health and Critical Care and IUI-IVF, we have the privilege of being a partner of choice.

BSV's products portfolio includes plasma derivatives, monoclonals, fertility hormones, antifungals, anaesthetics, cardiovascular drugs, and equine immunoglobulin /antitoxins.

In addition, BSV offers products in the areas of gynaecology, assisted reproductive technology, critical care, emergency medicine, neurology, nephrology, haematology, and urology.